Excitement for the SGLT2 inhibitor class continued at the 2019 ASN Kidney Week. Evidence continues to accumulate from analyses of the CREDENCE trial which originally showed - for the first time in a randomized controlled study with hard renal outcome…
.cokRefs { clear: both } .cokRefs p { margin: 0; padding: 0 } .cokRefs a { font-weight: normal } .dykCoNPearl { clear: both; margin-top: 80px } Welcome to the Circle of Knowledge Program Two Canadian e…
Welcome to the Circle of Knowledge Program Two Canadian experts, Dr. Jordan Weinstein and Dr. Louis Girard, nephrologists, will share how to translate clinical evidence into daily practice for optimal hypertension patient care. www.CircleofKnowledg…
Welcome to the Circle of Knowledge Program Two Canadian experts, Dr. Jordan Weinstein and Dr. Louis Girard, nephrologists, will share how to translate clinical evidence into daily practice for optimal hypertension patient care. www.CircleofKnowledg…
